TITLE

Controversies about occult hepatitis B virus infection

AUTHOR(S)
Ozaslan, Ersan; Purnak, Tugrul; Prieto, Jesus
PUB. DATE
October 2009
SOURCE
World Journal of Gastroenterology;10/21/2009, Vol. 15 Issue 39, p4986
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
We read with great interest the paper written by Shi et al, reviewing the molecular characteristics and stages of chronic hepatitis B virus (HBV) infection. We think that some points in the definition of occult HBV infection (OBI) and their conclusion about the management of OBI may need further considerations.
ACCESSION #
44861337

 

Related Articles

  • Lamivudine for the Treatment of Chronic Hepatitis B. Verhelst, David; Goffin, Eric // New England Journal of Medicine;02/24/2000, Vol. 342 Issue 8, p592 

    A letter to the editor is presented in response to an article focusing on the treatment of chronic Hepatitis B, by J.L. Dienstag and others in the October 21, 1999 issue.

  • Lamivudine for the Treatment of Chronic Hepatitis B. Dienstag, Jules L.; Brown, Nathaniel A.; Woessner, Mary // New England Journal of Medicine;02/24/2000, Vol. 342 Issue 8, p592 

    A response by Jules L. Dienstag, Nathaniel A. Brown and Mary Woessner to a letter to the editor about their article focusing on the treatment of chronic Hepatitis in the October 21, 1999 issue is presented.

  • IN RESPONSE. Henry L. Y. Chan; Joseph J. Y. Sung // Annals of Internal Medicine;9/6/2005, Vol. 143 Issue 5, p391 

    Presents a response from authors to a letter to the editor on their article about pegylated interferon in patients with hepatitis B, published previously in the journal "Annals of Internal Medicine."

  • Cost-effectiveness in hepatitis B. Weitzman, Gil; Jacobson, Ira // Annals of Internal Medicine;11/15/2005, Vol. 143 Issue 10, p757 

    Presents a letter to the editor about cost-effectiveness in Hepatitis B.

  • IN RESPONSE. Spiegel, Brennan M. R.; Martin, Paul; Kanwal, Fasiha // Annals of Internal Medicine;11/15/2005, Vol. 143 Issue 10, p758 

    Presents a response by the author to a letter to the editor about his article on the management of chronic hepatitis B infection.

  • Knowledge of the Pre-Core Mutation Variant of the Hepatitis B Virus. Lyra, Luiz; Parana, Raymundo; Cotrim, Helma // American Journal of Gastroenterology;Dec1991, Vol. 86 Issue 12, p1851 

    Presents a letter to the editor about the pre-core mutation variant of the hepatitis B virus.

  • Acute Hepatitis B in a Patient with Antibodies to Hepatitis B Surface Antigen Who Was Receiving Rituximab. Dervite, Isabelle; Hober, Didier; Morel, Pierre // New England Journal of Medicine;01/04/2001, Vol. 344 Issue 1, p68 

    A letter to the editor on acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was having rituximab therapy is presented.

  • Peginterferon and Lamivudine for Hepatitis B. Assy, N. Nimer; Hussein, Osamah // New England Journal of Medicine;12/30/2004, Vol. 351 Issue 27, p2879 

    A letter to the editor is presented in response to the article "Peginterferon and Lamivudine for Hepatitis B," by Partick Marcellin in the September 16, 2004 issue.

  • Peginterferon and Lamivudine for Hepatitis B. Marcellin, Patrick // New England Journal of Medicine;12/30/2004, Vol. 351 Issue 27, p2879 

    A response by Patrick Marcellin to a letter to the editor about his article "Peginterferon and Lamivudine for Hepatitis B" in the September 16, 2007 issue is presented.

  • Long-term lamivudine therapy in hepatitis B-associated membranous nephropathy? Y.-Y. Ng; W.-C. Yang; S.-T. Lee // Kidney International;Feb2006, Vol. 69 Issue 4, p776 

    A letter to the editor is presented in response to the article "Long-Term Lamivudine Therapy in Hepatitis B-Associated Membranous Nephropathy?" in the January 18, 2006 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics